Trade Tariffs and Their Impact on Pharmaceuticals
Explore the impact of trade tariffs on the pharmaceutical industry with the new EU-US trade deal imposing up to 15% tariffs.
Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
Local Medicine Manufacturing and National Health Security
Explore the future of local medicine manufacturing as Sahpra fast-tracks evaluation to secure South Africa's national supply.
Malaria Breakthrough: First Treatment for Babies
Coartem Baby offers a vital solution for malaria in infants, marking a historic advancement in child health.
Dis-Chem Grapples with Retail Squeeze and Fierce Competition
The group identifies limited availability of profitable locations as a key risk to its expansion strategy, which relies on opening new stores and acquiring independent pharmacies.
Are New Cancer Treatments Worth the Price?
Learn about the cost of cancer treatments and the reality behind their effectiveness. Are patients getting the care they deserve?
Ozempic and Mounjaro are reshaping South Africa’s health market
Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.
Trump targets drug costs in sweeping executive order
Trump targets drug costs with a new executive order to lower prescription prices to align with international rates.
Pharmaceutical tariffs could hike drug costs by billions
Learn how pharmaceutical tariffs could raise U.S. drug costs by nearly $51 billion and impact American consumers.
Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.